Nemaura Competitors

Delisted . USA . 
Stock . Nemaura Medical
Nemaura Medical competes with Neuropace, CVRx, Orthofix Medical, Artivion, and Bluejay Diagnostics; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Nemaura Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Nemaura Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Nemaura Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Nemaura Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Nemaura Medical and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Nemaura and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Nemaura Medical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
MODD
+ 0.84
MOVE
AORT
+ 0.8
OFIX
AORT
+ 0.78
CVRX
MOVE
+ 0.71
AORT
CVRX
+ 0.69
NPCE
NVNO
+ 0.68
NPCE
  
High negative correlations   
NVNO
- 0.35
BJDX
BJDX
- 0.32
NPCE
BJDX
- 0.31
CVRX
MODD
- 0.22
NVNO
BJDX
- 0.21
AORT
MODD
- 0.14
NPCE

Risk-Adjusted Indicators

There is a big difference between Nemaura Pink Sheet performing well and Nemaura Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nemaura Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NPCE  3.14  0.14  0.00 (0.04) 0.00 
 0.00 
 5.89 
(6.82)
 17.98 
CVRX  3.03 (0.04) 0.00 (0.17) 0.00 
 0.00 
 5.58 
(6.75)
 14.59 
OFIX  1.22 (0.08) 0.00 (0.24) 0.00 
 0.00 
 2.18 
(2.74)
 6.60 
AORT  1.40 (0.26) 0.00 (0.64) 0.00 
 0.00 
 2.86 
(2.60)
 13.14 
HSKA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BJDX  6.24 (0.06) 0.00 (0.18) 0.00 
 0.00 
 12.20 
(15.29)
 42.86 
MOVE  3.52 (0.89) 0.00 (1.03) 0.00 
 0.00 
 6.72 
(13.22)
 32.07 
INVO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
NVNO  3.06  0.15  0.00 (0.03) 0.00 
 0.00 
 8.51 
(6.90)
 28.92 
MODD  2.72 (0.87) 0.00 (1.73) 0.00 
 0.00 
 4.76 
(7.14)
 18.21 
All Fundamental Data

Nemaura Medical Competitive Analysis

The better you understand Nemaura Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Nemaura Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Nemaura Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NPCE CVRX OFIX AORT BJDX MOVE NVNO MODD NXL SSKN
 2.49 
 10.69 
Neuropace
 3.53 
 11.44 
CVRx
 1.41 
 16.53 
Orthofix
 2.99 
 24.12 
Artivion
 1.51 
 4.04 
Bluejay
 2.21 
 2.65 
Movano
 4.30 
 2.91 
EnVVeno
 2.27 
 0.90 
Modular
 10.26 
 2.15 
Nexalin
 2.21 
 2.78 
STRATA
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Somewhat reliable
Very steady
Very steady
Very risky
Slightly risky
Moderately volatile
Risky
Dangerous
Slightly risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Very High
Very High
Below Average
Low
Very High
Low
Low
Low
Above Average
High
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Strong Buy
Buy
Strong Buy
Not Available
Buy
Strong Buy
Strong Buy
Hold
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Hold
Strong Hold
Strong Hold
Buy
Cautious Hold
Buy
Strong Sell
Cautious Hold
Hold
Current Ratio
9.86
16.82
3.15
5.77
17.41
6.78
20.79
14.09
0.2
1.3
Net Asset
94.65 M
133.41 M
893.29 M
789.1 M
4.87 M
9.42 M
44.95 M
13.81 M
3.63 M
42.02 M
Profit Margin
-0.34
-1.17
-0.16
-0.0344
N/A
N/A
N/A
N/A
N/A
-0.29
EBITDA
(16.57 M)
(54.89 M)
(18.24 M)
50.97 M
(9.17 M)
(29.12 M)
(23.83 M)
(17.1 M)
(5.69 M)
(3.38 M)
Current Valuation
360.19 M
232.2 M
750.41 M
1.3 B
(3.3 M)
6.81 M
8.24 M
29.31 M
26.99 M
20.76 M
Price To Book
42.38
4.05
1.3
3.58
0.31
1.75
1.19
3.45
6.04
1.21
Operating Margin
-0.17
-0.67
-0.0359
0.0396
N/A
-31.99
N/A
N/A
-69.62
-0.19
Retained Earnings
(530.95 M)
(537.35 M)
(276.14 M)
(61.27 M)
(26.95 M)
(124.38 M)
(151.85 M)
(65.93 M)
(77.04 M)
(238.06 M)
Current Asset
N/A
N/A
147.87 M
N/A
N/A
138.64 M
N/A
N/A
N/A
9.39 M
Beta
2.07
1.29
1.06
1.79
0.38
0.19
1.38
-3.97
4.39
1.33
Number Of Employees
184
206
1.62 K
1.6 K
10
30
37
39
6
99
Shares Outstanding
32.56 M
26.04 M
39.02 M
42.05 M
552.85 K
6.6 M
17.54 M
40.67 M
13.3 M
4.17 M
Cash Flow From Operations
(17.95 M)
(39.14 M)
25.79 M
22.24 M
(8.31 M)
(26.18 M)
(16.84 M)
(13.95 M)
(3.84 M)
(519 K)
Total Debt
73.34 M
50.15 M
179.63 M
8.12 M
352.98 K
217 K
1.06 M
1.19 M
4.46 K
15.63 M
Return On Equity
-1.89
-0.82
-0.23
-0.0479
-1.39
-1.81
-0.49
-2.58
-1.36
-0.73
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.13
-0.3
-0.045
0.0221
-0.61
-0.89
-0.32
-1.25
-0.84
-0.0885
Number Of Shares Shorted
227.95 K
1.93 M
654.34 K
3.83 M
15.13 K
55.19 K
427.14 K
296.98 K
355.87 K
590
Book Value Per Share
0.27
2.81
13.07
6.59
20.09
2.54
2.4
0.25
0.39
2.24
Current Liabilities
N/A
N/A
52.94 M
N/A
N/A
40.62 M
N/A
N/A
N/A
4.62 M
Total Asset
94.65 M
133.41 M
893.29 M
789.1 M
4.87 M
9.42 M
44.95 M
13.81 M
3.63 M
42.02 M
Short Ratio
0.82
9.59
3.98
8.96
0.66
3.76
5.4
3.7
0.99
0.47
Target Price
17.57
19.83
24.3
32.33
256.0
30.0
16.5
8.0
3.0
11.0
Debt To Equity
1.08
0.003
0.078
1.27
0.036
0.025
0.04
0.011
N/A
0.35
Shares Owned By Institutions
61.72
70.56
86.61
91.99
6.7
13.84
24.37
43.57
2.88
63.8
Market Capitalization
339.6 M
287.7 M
636.07 M
984.76 M
2.2 M
27.72 M
48.93 M
35.91 M
25.94 M
11.35 M
Price To Earning
N/A
0.19
338.0
N/A
N/A
39.53
N/A
N/A
N/A
-0.49
Price To Earnings To Growth
N/A
N/A
0.33
181.5
N/A
N/A
N/A
N/A
N/A
-0.02
Price To Sales
4.25
5.61
0.8
2.53
54.99
19.93
N/A
N/A
160.06
0.35
Net Income
(27.14 M)
(59.97 M)
(126 M)
(13.36 M)
(9.95 M)
(29.28 M)
(21.82 M)
(17.47 M)
(4.65 M)
(10.83 M)
Earnings Per Share
-0.93
-2.65
-3.3
-0.32
-804.0
-5.8
-1.27
-0.53
-0.65
-2.6
Shares Owned By Insiders
3.38
4.9
5.33
5.8
0.69
17.33
0.8
8.26
19.22
2.91
Revenue
79.91 M
51.29 M
799.49 M
388.54 M
N/A
N/A
N/A
N/A
110.75 K
33.36 M
Working Capital
66.18 M
119.05 M
264.66 M
223.26 M
1.45 M
2.62 M
41.64 M
8.24 M
3 M
3.37 M
Cash And Equivalents
92.41 M
109.98 M
59.54 M
40.38 M
15.34 M
21.3 M
37.48 M
13.7 M
291.33 K
10.04 M
Cash Per Share
3.72
5.34
2.98
1.0
0.76
0.65
3.96
1.25
0.06
0.29
Gross Profit
59.09 M
42.96 M
558.07 M
248.78 M
48.91 K
N/A
N/A
N/A
127.75 K
18.12 M
Day Typical Price
10.67
11.47
16.43
23.96
4.03
2.7
2.9
0.88
2.1
2.71
Accumulation Distribution
2981.62
3535.33
3335.57
8935.01
2119.37
1167.31
2658.72
4202.67
12625.2
187.13
Market Facilitation Index
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.0E-4
Daily Balance Of Power
0.7879
0.8125
0.6389
1.186441
0.1667
(0.38)
0.8571
0.3333
0.8333
0.2143
Period Momentum Indicator
0.26
0.39
0.23
0.7
0.06
(0.06)
0.12
0.02
0.2
0.06
Rate Of Daily Change
1.02
1.04
1.01
1.03
1.02
0.98
1.04
1.02
1.1
1.02
Day Median Price
10.66
11.48
16.38
23.89
4.02
2.72
2.89
0.87
2.08
2.67
Price Action Indicator
0.16
0.15
0.27
0.59
0.05
(0.10)
0.08
0.04
0.17
0.14
Coefficient Of Variation
(9,467)
(1,738)
(827.93)
(597.59)
(3,236)
(554.57)
(15,497)
(393.85)
(730.37)
(3,209)
Mean Deviation
3.14
3.03
1.22
1.4
6.24
3.52
3.06
2.72
5.37
2.15
Jensen Alpha
0.1373
(0.04)
(0.08)
(0.26)
(0.06)
(0.89)
0.1454
(0.87)
(0.64)
(0.04)
Total Risk Alpha
0.6139
0.4137
0.0631
(0.01)
1.2
(0.08)
0.7121
(0.33)
0.2023
0.4159
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Standard Deviation
3.95
3.82
1.53
1.97
8.79
5.64
4.46
3.71
6.72
3.1
Kurtosis
(0.07)
(0.51)
(0.55)
3.55
3.0
4.92
3.2
0.8468
0.0351
2.51
Potential Upside
5.89
5.58
2.18
2.86
12.2
6.72
8.51
4.76
10.76
5.15
Treynor Ratio
(0.04)
(0.17)
(0.24)
(0.64)
(0.18)
(1.03)
(0.03)
(1.73)
(0.45)
(0.22)
Maximum Drawdown
17.98
14.59
6.6
13.14
42.86
32.07
28.92
18.21
29.33
14.27
Variance
15.61
14.57
2.35
3.86
77.28
31.86
19.86
13.75
45.15
9.61
Market Risk Adjusted Performance
(0.03)
(0.16)
(0.23)
(0.63)
(0.17)
(1.02)
(0.02)
(1.72)
(0.44)
(0.21)
Risk Adjusted Performance
(0)
(0.04)
(0.1)
(0.14)
(0.02)
(0.14)
0.0027
(0.21)
(0.11)
(0.02)
Skewness
0.0559
(0.03)
(0.07)
(0.42)
(0.34)
(1.08)
0.7423
(0.08)
0.0538
0.8754
Semi Deviation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Information Ratio
0.0229
(0.02)
(0.03)
(0.10)
(0.02)
(0.16)
0.0232
(0.22)
(0.12)
0.0115
Value At Risk
(6.82)
(6.75)
(2.74)
(2.60)
(15.29)
(13.22)
(6.90)
(7.14)
(13.03)
(5.25)
Expected Short fall
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Nemaura Medical Competition Performance Charts

Five steps to successful analysis of Nemaura Medical Competition

Nemaura Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Nemaura Medical in relation to its competition. Nemaura Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Nemaura Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Nemaura Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Nemaura Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Nemaura Medical position

In addition to having Nemaura Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Basic Utilities Thematic Idea Now

Basic Utilities
Basic Utilities Theme
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Nemaura Pink Sheet

If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY